189 related articles for article (PubMed ID: 22191127)
41. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
[TBL] [Abstract][Full Text] [Related]
42. [Laparoscopy-assisted vaginal pelvic exenteration].
Ferron G; Querleu D; Martel P; Chopin N; Soulié M
Gynecol Obstet Fertil; 2006 Dec; 34(12):1131-6. PubMed ID: 17134933
[TBL] [Abstract][Full Text] [Related]
43. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
[TBL] [Abstract][Full Text] [Related]
44. [Possibilities and operative aspects of gynecologic urologic interventions in the treatment of malignant diseases of the pelvic organs].
Ackermann R
Gynakologe; 1985 Mar; 18(1):26-34. PubMed ID: 4007630
[No Abstract] [Full Text] [Related]
45. Utilization and perioperative outcome of minimally invasive pelvic exenteration in gynecologic malignancies: A national study in the United States.
Matsuo K; Matsuzaki S; Mandelbaum RS; Kanao H; Chang EJ; Klar M; Roman LD; Wright JD
Gynecol Oncol; 2021 Apr; 161(1):39-45. PubMed ID: 33402282
[TBL] [Abstract][Full Text] [Related]
46. Pelvic exenterations for gynecological malignancies: a study of 36 cases.
Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477
[TBL] [Abstract][Full Text] [Related]
47. The role of palliative pelvic exenteration.
Brophy PF; Hoffman JP; Eisenberg BL
Am J Surg; 1994 Apr; 167(4):386-90. PubMed ID: 7513967
[TBL] [Abstract][Full Text] [Related]
48. Laparoscopy-assisted vaginal pelvic exenteration.
Ferron G; Querleu D; Martel P; Letourneur B; Soulié M
Gynecol Oncol; 2006 Mar; 100(3):551-5. PubMed ID: 16249020
[TBL] [Abstract][Full Text] [Related]
49. Urologic complications of pelvic exenteration for gynecologic malignancy.
Fallon B; Loening S; Hawtrey CE; Lifshitz SG; Buchsbaum HJ
J Urol; 1979 Aug; 122(2):158-9. PubMed ID: 459005
[TBL] [Abstract][Full Text] [Related]
50. Colorectal function preservation in posterior and total supralevator exenteration for gynecologic malignancies: an 89-patient series.
Moutardier V; Houvenaeghel G; Lelong B; Mokart D; Delpero JR
Gynecol Oncol; 2003 Apr; 89(1):155-9. PubMed ID: 12694670
[TBL] [Abstract][Full Text] [Related]
51. [Exenteration of pelvic organs and its modifications].
Gotsadze DT
Vopr Onkol; 1997; 43(6):653-6. PubMed ID: 9479371
[TBL] [Abstract][Full Text] [Related]
52. Pelvic exenteration. Has it a role in 1987? A six year experience.
Shepherd JH
Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
[TBL] [Abstract][Full Text] [Related]
53. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A
Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392
[TBL] [Abstract][Full Text] [Related]
54. Choices in creating continent urostomies following pelvic exenteration for gynecologic malignancies.
Silver DF; Ashwell TR
Gynecol Oncol; 2001 Sep; 82(3):510-5. PubMed ID: 11520148
[TBL] [Abstract][Full Text] [Related]
55. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
56. Pelvic exenterations for gynecologic cancers: A retrospective analysis of a 30-year experience in a cancer center.
Knight S; Lambaudie E; Sabiani L; Mokart D; Provansal M; Tallet A; Houvenaeghel G
Eur J Surg Oncol; 2018 Dec; 44(12):1929-1934. PubMed ID: 30262326
[TBL] [Abstract][Full Text] [Related]
57. Urological complications after cystectomy as part of pelvic exenteration are higher than that after cystectomy for primary bladder malignancy.
Brown KG; Solomon MJ; Latif ER; Koh CE; Vasilaras A; Eisinger D; Sved P
J Surg Oncol; 2017 Mar; 115(3):307-311. PubMed ID: 27859276
[TBL] [Abstract][Full Text] [Related]
58. [Vaginal reconstruction after pelvic exenteration: when and which techniques?].
Ferron G; Martel P; Querleu D
Bull Cancer; 2003 May; 90(5):435-40. PubMed ID: 12868455
[TBL] [Abstract][Full Text] [Related]
59. Minimally invasive pelvic exenteration for gynaecological malignancy: A single-centre case series and review of the literature.
Karkia R; Tailor A; Ellis P; Madhuri T; Scala A; Read J; Perry M; Patil K; Blackburn A; Butler-Manuel S; Chatterjee J
Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():56-61. PubMed ID: 35584578
[TBL] [Abstract][Full Text] [Related]
60. Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome.
Andikyan V; Khoury-Collado F; Gerst SR; Talukdar S; Bochner BH; Sandhu JS; Abu-Rustum N; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2012 Sep; 126(3):346-50. PubMed ID: 22555107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
